Research Shows Pharmaceutical Ads Can Sway AI Treatment Recommendations

A new study from Mount Sinai, published in The Lancet Digital Health, reveals that clearly labeled pharmaceutical advertisements can influence treatment recommendations from AI models. Researchers tested 12 AI models and found that when a clinical case was preceded by a drug ad, the AI was more likely to suggest the advertised drug in 33 scenarios. This raises significant concerns about commercial advertising's impact on AI-driven health information and patient safety.